Publication | Closed Access

Simulation of MDM2 N-terminal domain conformational lability in the presence of imidazoline based inhibitors of MDM2-p53 protein–protein interaction

EngineeringBiochemistryMedicineRational Drug DesignMolecular BiologyConformational StudyProtein ModelingMolecular SimulationMdm2-p53 Protein–protein InteractionMolecular DockingMolecular ModelingMolecular DynamicsStructural BiologyDrug Discovery